Workflow
Hodgkin lymphoma
icon
Search documents
Bristol Myers Secures FDA Nod For Opdivo Plus Chemo For Untreated Hodgkin Lymphoma
Benzinga· 2026-03-20 17:57
• Bristol-Myers Squibb shares are experiencing downward pressure. Why is BMY stock retreating?Hodgkin lymphoma (HL) is a cancer in which multinucleated Reed–Sternberg cells (RS cells) are present in the lymph nodes.Autologous hematopoietic stem cell transplantation (HSCT) and brentuximab vedotin.Three or more lines of systemic therapy that include autologous HSCT.Nivolumab received accelerated approval for these indications in 2016 and 2017, respectively.Bristol Myers Efficacy and SafetyEfficacy of nivolum ...